Dan Brennan
Stock Analyst at TD Cowen
(4.13)
# 593
Out of 4,479 analysts
57
Total ratings
58.73%
Success rate
9.85%
Average return
Main Sectors:
22 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ILMN Illumina | Maintains: Hold | $140 → $122 | $105.50 | +15.64% | 4 | Jun 6, 2024 | |
| A Agilent Technologies | Maintains: Buy | $163 → $153 | $127.40 | +20.09% | 9 | May 30, 2024 | |
| BDSX Biodesix | Initiates: Buy | $2.8 | $1.53 | +83.01% | 1 | May 13, 2024 | |
| NTRA Natera | Maintains: Buy | $123 → $137 | $107.81 | +27.08% | 2 | May 10, 2024 | |
| WAT Waters | Maintains: Hold | $350 → $358 | $282.70 | +26.64% | 1 | May 8, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $21 → $20 | $13.93 | +43.58% | 6 | May 1, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $57 → $32 | $18.59 | +72.14% | 4 | May 1, 2024 | |
| RVTY Revvity | Maintains: Buy | $123 → $130 | $103.00 | +26.21% | 1 | Apr 30, 2024 | |
| WGS GeneDx Holdings | Maintains: Buy | $14 → $24 | $28.69 | -16.35% | 1 | Apr 30, 2024 | |
| DHR Danaher | Maintains: Buy | $280 → $290 | $244.51 | +18.60% | 3 | Apr 24, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $240 → $300 | $208.49 | +43.89% | 2 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $270 → $290 | $203.24 | +42.69% | 3 | Feb 15, 2024 | |
| AVTR Avantor | Upgrades: Outperform | $28 | $20.77 | +34.81% | 2 | Dec 11, 2023 | |
| LULU Lululemon Athletica | Maintains: Outperform | $545 → $546 | $302.36 | +80.58% | 4 | Dec 8, 2023 | |
| MDXH MDxHealth | Initiates: Outperform | $7 | $2.36 | +196.61% | 1 | May 31, 2023 | |
| TMO Thermo Fisher | Maintains: Outperform | $711 → $693 | $541.72 | +27.93% | 4 | Apr 27, 2023 | |
| VZ Verizon | Maintains: Outperform | $49 → $45 | $41.74 | +7.81% | 1 | Apr 26, 2023 | |
| PACB Pacific Biosciences of California | Upgrades: Outperform | $13 → $15 | $1.20 | +1,150.00% | 1 | Mar 31, 2023 | |
| EXAS Exact Sciences | Maintains: Outperform | $56 → $76 | $42.43 | +79.12% | 3 | Feb 22, 2023 | |
| MRVI Maravai LifeSciences Holdings | Downgrades: Neutral | $20 → $16 | $6.94 | +130.55% | 2 | Jan 5, 2023 | |
| ICLR ICON PLC | Upgrades: Buy | n/a | $316.51 | - | 1 | Mar 1, 2021 | |
| MTD Mettler-Toledo International | Downgrades: Sell | n/a | $1,366.84 | - | 1 | Oct 7, 2020 |
Illumina
Jun 6, 2024
Maintains: Hold
Price Target: $140 → $122
Current: $105.50
Upside: +15.64%
Agilent Technologies
May 30, 2024
Maintains: Buy
Price Target: $163 → $153
Current: $127.40
Upside: +20.09%
Biodesix
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $1.53
Upside: +83.01%
Natera
May 10, 2024
Maintains: Buy
Price Target: $123 → $137
Current: $107.81
Upside: +27.08%
Waters
May 8, 2024
Maintains: Hold
Price Target: $350 → $358
Current: $282.70
Upside: +26.64%
NeoGenomics
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $13.93
Upside: +43.58%
10x Genomics
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $18.59
Upside: +72.14%
Revvity
Apr 30, 2024
Maintains: Buy
Price Target: $123 → $130
Current: $103.00
Upside: +26.21%
GeneDx Holdings
Apr 30, 2024
Maintains: Buy
Price Target: $14 → $24
Current: $28.69
Upside: -16.35%
Danaher
Apr 24, 2024
Maintains: Buy
Price Target: $280 → $290
Current: $244.51
Upside: +18.60%
IQVIA Holdings
Feb 15, 2024
Maintains: Buy
Price Target: $240 → $300
Current: $208.49
Upside: +43.89%
Charles River Laboratories International
Feb 15, 2024
Maintains: Buy
Price Target: $270 → $290
Current: $203.24
Upside: +42.69%
Avantor
Dec 11, 2023
Upgrades: Outperform
Price Target: $28
Current: $20.77
Upside: +34.81%
Lululemon Athletica
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $302.36
Upside: +80.58%
MDxHealth
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $2.36
Upside: +196.61%
Thermo Fisher
Apr 27, 2023
Maintains: Outperform
Price Target: $711 → $693
Current: $541.72
Upside: +27.93%
Verizon
Apr 26, 2023
Maintains: Outperform
Price Target: $49 → $45
Current: $41.74
Upside: +7.81%
Pacific Biosciences of California
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.20
Upside: +1,150.00%
Exact Sciences
Feb 22, 2023
Maintains: Outperform
Price Target: $56 → $76
Current: $42.43
Upside: +79.12%
Maravai LifeSciences Holdings
Jan 5, 2023
Downgrades: Neutral
Price Target: $20 → $16
Current: $6.94
Upside: +130.55%
ICON PLC
Mar 1, 2021
Upgrades: Buy
Price Target: n/a
Current: $316.51
Upside: -
Mettler-Toledo International
Oct 7, 2020
Downgrades: Sell
Price Target: n/a
Current: $1,366.84
Upside: -